MDT - Company ID 0001613103
The table below shows Medtronic plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B |
| Cost of revenue | $11.63B | $11.22B | $10.72B | $10.14B | $10.48B | $9.42B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Medtronic plc reported annual revenue of $33.54B for fiscal year 2025. That is up 3.6% from $32.36B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $28.83B (FY 2016) to $33.54B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.85B |
| $10.74B |
| $10.41B |
| $10.29B |
| $10.15B |
| $10.11B |
| Operating income | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B | $4.79B |
| Income tax | $936.00M | $1.13B | $1.58B | $456.00M | $265.00M | -$751.00M |
| Net income | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B |
| EPS (diluted) | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 |